.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Deloitte
Chinese Patent Office
Covington
Cantor Fitzgerald
QuintilesIMS
Chubb
Fuji
Boehringer Ingelheim

Generated: February 23, 2018

DrugPatentWatch Database Preview

Regulatory Exclusivity Expiring in 2023

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Exclusivity Expiration Patented / Exclusive Use
Vertex Pharms IncORKAMBIivacaftor; lumacaftorTABLET;ORAL206038-002Sep 28, 2016RXYesNo➤ Sign UpPEDIATRIC EXCLUSIVITY
Vertex Pharms IncORKAMBIivacaftor; lumacaftorTABLET;ORAL206038-001Jul 2, 2015RXYesYes➤ Sign UpPEDIATRIC EXCLUSIVITY
Aaa Usa IncLUTATHERAlutetium dotatate lu-177SOLUTION;IV (INFUSION)208700-001Jan 26, 2018RXYesYes➤ Sign UpNEW CHEMICAL ENTITY
Eisai IncHALAVENeribulin mesylateSOLUTION;INTRAVENOUS201532-001Nov 15, 2010RXYesYes➤ Sign UpTREATMENT OF PATIENTS WITH UNRESECTABLE OR METASTATIC LIPOSARCOMA WHO HAVE RECEIVED A PRIOR ANTHRACYCLNE-CONTAINING REGIMEN
Horizon Pharma UsaPROCYSBIcysteamine bitartrateCAPSULE, DELAYED RELEASE;ORAL203389-001Apr 30, 2013RXYesNo➤ Sign UpPEDIATRIC EXCLUSIVITY
Horizon Pharma UsaPROCYSBIcysteamine bitartrateCAPSULE, DELAYED RELEASE;ORAL203389-002Apr 30, 2013RXYesYes➤ Sign UpPEDIATRIC EXCLUSIVITY
NovartisAFINITOReverolimusTABLET;ORAL022334-002Mar 30, 2009RXYesYes➤ Sign UpTREATMENT OF ADULT PATIENTS WITH PROGRESSIVE, WELL-DIFFERENTIATED, NON-FUNCTIONAL, NEUROENDOCRINE TUMORS (NET) OF GASTROINTESTINAL (GI) OR LUNG ORIGIN, (EXCLUDING PANCREATIC) WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC DISEASE
NovartisAFINITOReverolimusTABLET;ORAL022334-003Jul 9, 2010RXYesNo➤ Sign UpTREATMENT OF ADULT PATIENTS WITH PROGRESSIVE, WELL-DIFFERENTIATED, NON-FUNCTIONAL, NEUROENDOCRINE TUMORS (NET) OF GASTROINTESTINAL (GI) OR LUNG ORIGIN, (EXCLUDING PANCREATIC) WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC DISEASE
NovartisAFINITOReverolimusTABLET;ORAL022334-004Mar 30, 2012RXYesNo➤ Sign UpTREATMENT OF ADULT PATIENTS WITH PROGRESSIVE, WELL-DIFFERENTIATED, NON-FUNCTIONAL, NEUROENDOCRINE TUMORS (NET) OF GASTROINTESTINAL (GI) OR LUNG ORIGIN, (EXCLUDING PANCREATIC) WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC DISEASE
NovartisAFINITOReverolimusTABLET;ORAL022334-001Mar 30, 2009RXYesNo➤ Sign UpTREATMENT OF ADULT PATIENTS WITH PROGRESSIVE, WELL-DIFFERENTIATED, NON-FUNCTIONAL, NEUROENDOCRINE TUMORS (NET) OF GASTROINTESTINAL (GI) OR LUNG ORIGIN, (EXCLUDING PANCREATIC) WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC DISEASE
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
US Army
Chubb
Novartis
McKesson
Covington
Accenture
Healthtrust
Queensland Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot